United Health Products, Inc. (UEEC)

OTC Markets OTCQB

$0.04-7.89% today

Price as at 1 Oct 2026, 03:12 UTC. Quotes are delayed.

Fundamentals

52-week range$0.03 to $0.12

Valuation and ratings

United Health Products, Inc. trades at $0.04. We do not hold enough of the inputs to value this company with the confidence the estimate implies, so we publish no fair value for it rather than a number we would not defend.

About United Health Products, Inc.

United Health Products, Inc. develops, manufactures, and markets hemostatic gauze products for the healthcare and wound care sectors in the United States. The company offers CelluSTAT hemostatic gauze products to absorb exudate/drainage from superficial wounds, as well as helps in controlling bleeding. It serves hospitals and surgery centers, clinics and physicians, military medical care providers, hemodialysis centers, nursing homes and assisted living, and veterinary hospitals; and EMS, fire departments, and other first responders, as well as dental, oral, and maxillofacial surgery offices. The company was formerly known as United EcoEnergy Corp. and changed its name to United Health Products, Inc. in September 2010. The company was incorporated in 1997 and is headquartered in Mount Laurel, New Jersey.

Industry: Medical Instruments & SuppliesHQ: United States

Company profile, industry and headcount are as reported by our data provider and can lag a company's own filings by a reporting period. The annual report is the authority.

Common questions

Where does SteadyShares get its UEEC data?

Fundamentals for UEEC come from company filings and exchange data, as listed on OTC Markets OTCQB; institutional ownership comes from SEC 13F filings. The share price shown was last refreshed on 1 Oct 2026, 03:12 UTC and is delayed. Metrics we do not hold are left out of the page rather than estimated.

The full research page for UEEC, with financial statements, ownership detail, peer comparison and alerts, is free inside the app.

Data from company filings, exchange quotes and SEC EDGAR 13F disclosures. Quotes are delayed. Metrics we do not have are left out rather than estimated. Educational information, not financial advice.